The history of Viagra and its originator, copyright, presents a tangled picture for cautious investors. While the revolutionary drug initially generated enormous profits , its exclusivity has lapsed , leading to generic alternatives flooding the market . This decline in pricing presents a real challenge for copyright and any portfolio considering a